Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy

Journal of Cardiac Failure

Volumn 17, Issue 5, 2011, Pages 384-391

  Aquaro, Giovanni Donato ^a,f   Todiere, Giancarlo ^b   Barison, Andrea ^c   Strata, Elisabetta ^d   Marzilli, Mario ^b   Pingitore, Alessandro ^e   Lombardi, Massimo ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^f Via Moruzzi 1 ^*  (Italy)

Author keywords

cardiac magnetic resonance; Hypertrophic cardiomyopathy; late gadolinium enhancement; myocardial blood flow; myocardial fibrosis

Indexed keywords

GADOLINIUM PENTETATE;

ACROMEGALY; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

ADULT; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY VESSELS; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 79955611720     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.01.006     Document Type: Article

References (30)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320 (Pubitemid 34250486)
2. B.J. Maron Sudden death in young athletes N Engl J Med 349 2003 1064 1075 (Pubitemid 37098275)
3. A.M. Varnava, P.M. Elliott, C. Baboonian, F. Davison, M.J. Davies, and W.J. McKenna Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease Circulation 104 2001 1380 1384 (Pubitemid 32880150)
4. Bruder O, Wagner A, Jensen CJ, MD, Ong SP, Kispert E, Nassenstein K, et al. Myocardial Scar visualized by cardiovascular magnetic resonance imaging predicts major events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
5. O'Hanlon R, Grasso A, Roughton M, Moon JC, MD, Clark S, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
6. C. Basso, G. Thiene, D. Corrado, G. Buja, P. Melacini, and A. Nava Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Hum Pathol 31 2000 988 998
7. F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P.G. Camici Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 349 2003 1027 1035 (Pubitemid 37087617)
8. M.S. Maron, I. Olivotto, B.J. Maron, S.K. Prasad, F. Cecchi, and J.E. Udelson The case for myocardial ischemia in hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 866 875
9. A.C. Van Rossum, F.C. Visser, M.B. Hofman, M.A. Galjee, N. Westerhof, and J. Valk Global left ventricular perfusion: noninvasive measurement with cine MR imaging and phase velocity mapping of coronary venous outflow Radiology 182 1992 685 691
10. J. Schwitter, T. DeMarco, S. Kneifel, G.K. von Schulthess, M.C. Jörg, and H. Arheden Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography Circulation 101 2000 2696 2702 (Pubitemid 30390572)
11. J.W. Koskenvuo, J.J. Hartiala, J. Knuuti, H. Sakuma, J.O. Toikka, and M. Komu Assessing coronary sinus blood flow in patients with coronary artery disease: a comparison of phase-contrast MR imaging with positron emission tomography AJR 177 2001 1161 1168
12. K.M. Anderson, P.M. Odell, P.W. Wilson, and W.B. Kannel Cardiovascular disease risk profiles Am Heart J 121 1990 293 298
13. G.K. Lund, M.F. Wendland, A. Shimakawa, H. Arheden, F. Sthlberg, C.B. Higgins, and M. Saeed Coronary sinus flow measurement by means of velocity-encoded cine MR imaging: validation by using flow probes in dogs Radiology 217 2000 487 493
14. P.D. Gatehouse Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements J Cardiovasc Magn Reson 14 2010 12 15
15. U. Sechtem, P.W. Pflugfelder, R.G. Gould, M.M. Cassidy, and C.B. Higgins Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging Radiology 163 1987 697 702 (Pubitemid 17083233)
16. K.C. Vinnakota, and J.B. Bassingthwaighte Myocardial density and composition: a basis for calculating intracellular metabolite concentrations Am J Physiol Heart Circ Physiol 286 2004 1742 1749
17. K. Kawaji, N.C.F. Codella, M.R. Prince, C.W. Chu, A. Shakoor, and T.M. LaBounty Automated segmentation of routine clinical cardiac magnetic resonance imaging for assessment of left ventricular diastolic dysfunction Circ Cardiovasc Imaging 2 2009 476 484
18. N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, and T. Nakano Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects Radiology 211 1999 129 135 (Pubitemid 29161742)
19. G.D. Aquaro, A. Pingitore, P.G. Masci, F. Formisano, A. Barison, and E. Strata Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic Am J Cardiol 105 2010 392 397
20. R. Krams, M.J. Kofflard, D.J. Duncker, C. Von Birgelen, S. Carlier, and M. Kliffen Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodelling of the coronary microcirculation Circulation 97 1998 230 233 (Pubitemid 28067305)
21. R. Krams, F.J. ten Cate, S.G. Carlier, A.F. van der Steen, and P.W. Serruys Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 670 677 (Pubitemid 38229543)
22. F. Bogazzi, M. Lombardi, E. Strata, G.D. Aquaro, V. di Bello, C. Cosci, and C. Sardella High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging Clin Endocrinol 68 2008 261 368
23. E.D. Wigle, Z. Sasson, M.A. Henderson, T.D. Ruddy, J. Fulop, and H. Rakowski Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review Prog Cardiovasc Dis 28 1985 1 83 (Pubitemid 15237515)
24. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785 (Pubitemid 30390237)
25. P.M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat, and A. Varnava Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
26. A.S. Adabag, S.A. Casey, M.A. Kuskowski, A.G. Zenovich, and B.J. Maron Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy J Am Coll Cardiol 45 2005 697 704 (Pubitemid 40278968)
27. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, and M.S. Link Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412 (Pubitemid 47124061)
28. I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, and F. Girolami Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
29. M.B. Hofman, F.C. Visser, A.C. van Rossum, G.Q. Vink, M. Sprenger, and N. Westerhof In vivo validation of magnetic resonance blood volume flow measurements with limited spatial resolution in small vessels Magn Reson Med 33 1995 778 784
30. A.C. van Rossum, F.C. Visser, M.B.M. Hofman, M.A. Galjee, N. Westerhof, and J. Valk Global left ventricular perfusion: noninvasive measurement with cine MR imaging and phase velocity mapping of coronary venous outflow Radiology 182 1992 685 691